Radoff Bradley Louis: insider trades.
Radoff Bradley Louis reported 9 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 7 open-market purchases ($19K) and 2 sales ($6K), across 1 company.
- Transactions
- 9
- Purchases (P)
- 7
- Sales (S)
- 2
- Companies
- 1
- Name as filed
- Radoff Bradley Louis
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Regional Health Properties, Inc (RHEP) | Other, TenPercentOwner | 9 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-15 | Regional Health Properties, Inc | S | 100 | $1.06 | 105,900 | Form 4 |
| 2026-06-05 | Regional Health Properties, Inc | S | 5,000 | $1.15 | 106,000 | Form 4 |
| 2026-04-29 | Regional Health Properties, Inc | P | 1,009 | $1.42 | 111,000 | Form 4 |
| 2026-04-27 | Regional Health Properties, Inc | P | 1,000 | $1.4 | 109,991 | Form 4 |
| 2026-04-22 | Regional Health Properties, Inc | P | 500 | $1.4 | 108,991 | Form 4 |
| 2026-04-22 | Regional Health Properties, Inc | P | 2,000 | $1.43 | 220,737 | Form 4 |
| 2026-04-14 | Regional Health Properties, Inc | P | 3,511 | $1.3 | 218,737 | Form 4 |
| 2026-04-13 | Regional Health Properties, Inc | P | 6,300 | $1.29 | 215,226 | Form 4 |
| 2026-04-13 | Regional Health Properties, Inc | P | 100 | $1.21 | 108,491 | Form 4 |
Questions
What stock did Radoff Bradley Louis buy or sell?
Radoff Bradley Louis reported 9 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 7 open-market purchases ($19K) and 2 sales ($6K), across 1 company.
Is Radoff Bradley Louis the same person as other filers with this name?
This page covers SEC CIK 1380585 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/radoff-bradley-louis-1380585.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.